Xiaoqian Hu

Zhejiang University - Centre for Health Policy Studies

China

SCHOLARLY PAPERS

4

DOWNLOADS

312

TOTAL CITATIONS

0

Scholarly Papers (4)

Health-Related Quality of Life of Type 2 Diabetes Inpatients with Diabetes-Related Complications in China

Number of pages: 24 Posted: 24 Jan 2019
Zhejiang University - Centre for Health Policy Studies, Shandong First Medical University - Shandong Provincial Hospital, Zhejiang University - Centre for Health Policy Studies, Shandong First Medical University - Shandong Provincial Hospital, Tulane University - School of Public Health and Tropical Medicine, Zhejiang University - Centre for Health Policy Studies, Zhejiang University - Centre for Health Policy Studies, Zhejiang University - Centre for Health Policy Studies and Zhejiang University - Centre for Health Policy Studies
Downloads 106 (564,749)

Abstract:

Loading...

Health-Related Quality of Life of Type 2 Diabetes Inpatients with Diabetes-Related Complications in China

Number of pages: 27 Posted: 23 Mar 2019
Zhejiang University - Centre for Health Policy Studies, Shandong First Medical University - Shandong Provincial Hospital, Zhejiang University - Centre for Health Policy Studies, Shandong First Medical University - Shandong Provincial Hospital, Zhejiang University - Centre for Health Policy Studies, Zhejiang University - Centre for Health Policy Studies, Zhejiang University - Centre for Health Policy Studies and Zhejiang University - Centre for Health Policy Studies
Downloads 36 (1,014,639)

Abstract:

Loading...

Health-Related Quality of Life; Type 2 Diabetes; Inpatients; Diabetes-Related Complications; China; cross-sectional study; utility; EQ-5D; ischemic heart disease; acute myocardial infarction; congestive heart failure; stroke; low vision; end-stage renal disease; ulcer; amputation

2.

Efficacy of Pharmacological Monotherapies for Type 2 Diabetes in China: A Systematic Review and Meta-Analysis

Number of pages: 41 Posted: 19 Mar 2019
Zhejiang University - Centre for Health Policy Studies, Zhejiang University - Centre for Health Policy Studies, Zhejiang University - Centre for Health Policy Studies, Zhejiang University - Centre for Health Policy Studies, Zhejiang University - Centre for Health Policy Studies, Zhejiang University - Centre for Health Policy Studies, McMaster University - Department of Health Research Methods, Evidence, and Impact (HEI), Tulane University - School of Public Health and Tropical Medicine and Zhejiang University - Centre for Health Policy Studies
Downloads 60 (786,394)

Abstract:

Loading...

3.

Efficacy and Safety of Pharmacological Combination Therapies for the Treatment of Type 2 Diabetes in China: A Systematic Review and Meta-Analysis

Number of pages: 57 Posted: 10 May 2019
Zhejiang University - Centre for Health Policy Studies, Zhejiang University - Centre for Health Policy Studies, Zhejiang University - Centre for Health Policy Studies, Zhejiang University - Centre for Health Policy Studies, Kaiser Permanente - Center for Health Policy Studies, Kaiser Permanente - Center for Health Policy Studies, Kaiser Permanente - Center for Health Policy Studies, Tulane University - School of Public Health and Tropical Medicine and Zhejiang University - Centre for Health Policy Studies
Downloads 58 (800,073)

Abstract:

Loading...

4.

Efficacy and Safety of Eight Classes of Glucose-Lowering Agents as Monotherapy for Type 2 Diabetes: A Systematic Review and Indirect Treatment Comparison

Number of pages: 36 Posted: 26 Feb 2020
Zhejiang University - Centre for Health Policy Studies, Zhejiang University - Centre for Health Policy Studies, Zhejiang University - Centre for Health Policy Studies, Tulane University - School of Public Health and Tropical Medicine, Zhejiang University - Centre for Health Policy Studies, Zhejiang University - Centre for Health Policy Studies and Zhejiang University - Centre for Health Policy Studies
Downloads 52 (844,502)

Abstract:

Loading...

efficacy; safety; glucose-lowering agent; monotherapy; type 2 diabetes; systematic review; meta-analysis; indirect treatment comparison; metformin; sulfonylurea; thiazolidinedione; α-glucosidase inhibitor; glinide; DPP-4 inhibitor; GLP-1 receptor agonist; insulin; glycosylated hemoglobin Alc; body m